Gornitzky represented Jefferies in the USD 10 million follow-on offering of Sol-Gel Technologies Ltd. on the NASDAQ Global Market.
Sol-Gel is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Jefferies LLC acted as the sole bookrunner for the offering.
Jefferies was represented by partners Chaim Friedland and Ari Fried along with associate Neta Peled.
